Dr. Krathen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
220 N Main St
Ste 201
Natick, MA 01760Phone+1 508-827-2615
Summary
- Dr. Michael Krathen is a dermatologist in Natick, MA and is affiliated with multiple hospitals in the area, including Emerson Hospital, Beth Israel Deaconess Hospital-Milton, and Newton-Wellesley Hospital. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 10 years. He specializes in acne & rosacea and cosmetic dermatology and is experienced in general dermatology, dermatologic surgery, cutaneous lymphomas, cosmetic dermatology, and non-melanoma skin cancer.
Education & Training
- Boston University Medical CenterResidency, Dermatology, 2008 - 2011
- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2007 - 2008
- Perelman School of Medicine at the University of PennsylvaniaClass of 2007
Certifications & Licensure
- CA State Medical License 2011 - Present
- FL State Medical License 2014 - 2026
- MA State Medical License 2009 - 2026
- OH State Medical License 2022 - 2026
- ME State Medical License 2022 - 2022
- PA State Medical License 2011 - 2011
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- 194 citationsPhase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collabor...Youn H. Kim, Mahkam Tavallaee, Uma Sundram, Katrin A. Salva, Gary S. Wood
Journal of Clinical Oncology. 2015-07-20 - 33 citationsLenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial.Lauren Okon, Misha Rosenbach, Michael Krathen, Mathew Rose, Kathleen J. Propert
Journal of the American Academy of Dermatology. 2014-03-01 - 46 citationsPharmacologic immunomodulation and cutaneous malignancy in rheumatoid arthritis, psoriasis, and psoriatic arthritis.Michael S. Krathen, Alice B. Gottlieb, Philip J. Mease
The Journal of Rheumatology. 2010-11-01
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: